Cargando…

miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins

OBJECTIVE: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yanqin, Hu, Bingshuang, Wang, Yanhong, Li, Zhen, Wu, Jingfang, Yang, Yunchu, Wei, Yue, Peng, Xiaofeng, Chen, Hongling, Chen, Rongqi, Jiang, Pingyan, Fang, Sixian, Yu, Zhiwu, Guo, Linlang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201844/
https://www.ncbi.nlm.nih.gov/pubmed/30425570
http://dx.doi.org/10.2147/CMAR.S178380
_version_ 1783365581515259904
author Sun, Yanqin
Hu, Bingshuang
Wang, Yanhong
Li, Zhen
Wu, Jingfang
Yang, Yunchu
Wei, Yue
Peng, Xiaofeng
Chen, Hongling
Chen, Rongqi
Jiang, Pingyan
Fang, Sixian
Yu, Zhiwu
Guo, Linlang
author_facet Sun, Yanqin
Hu, Bingshuang
Wang, Yanhong
Li, Zhen
Wu, Jingfang
Yang, Yunchu
Wei, Yue
Peng, Xiaofeng
Chen, Hongling
Chen, Rongqi
Jiang, Pingyan
Fang, Sixian
Yu, Zhiwu
Guo, Linlang
author_sort Sun, Yanqin
collection PubMed
description OBJECTIVE: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC) remains obscure. The objective of this study was to investigate the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. MATERIALS AND METHODS: All the experimental methods used were as follows: microarray analysis, cell culture, transient, and stable gene transfection; real-time fluorescence PCR; Western blot; flow cytometry for cell cycle analysis; in vitro proliferation assay; in vitro wound healing experiment; in vivo xenograft model in nude mice; and dual luciferase reporter assay. All statistical analyses were carried out using GraphPad Prism 7 software. Statistical significance was analyzed by Student’s t-test or one-way ANOVA. P <0.05 (typically compared with the negative control group) was considered as significant and is marked with an asterisk in the figures. RESULTS: In this study, we observed that miR-216a-5p is downregulated in SCLC cell lines compared to that in the normal human bronchial epithelial cell line 16-HBE. In vitro and in vivo experiments demonstrate that upregulation of miR-216a-5p significantly decreased cell growth and migration and its downregulation increased SCLC cell proliferation and migration and influenced the cell cycle. Using bioinformatics analyses, we predicted that the important antiapoptotic gene Bcl-2 is targeted by miR-216a-5p, and we identified a functional miR-216a-5p binding site in the 3′-UTR of Bcl-2 using luciferase reporter assay. Furthermore, we determined that suppression of miR-216a-5p modulated the expression of Bcl-2, Bax, and Bad proteins (Bcl-2 family proteins), while Bcl-2 knockdown abrogated the effect of miR-216a-5p downregulation on cell proliferation, cell migration, and the cell cycle. CONCLUSION: Taken together, these findings suggest that miR-216a-5p regulates SCLC biology via Bcl-2 family proteins. Therefore, our study highlights the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis.
format Online
Article
Text
id pubmed-6201844
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62018442018-11-13 miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins Sun, Yanqin Hu, Bingshuang Wang, Yanhong Li, Zhen Wu, Jingfang Yang, Yunchu Wei, Yue Peng, Xiaofeng Chen, Hongling Chen, Rongqi Jiang, Pingyan Fang, Sixian Yu, Zhiwu Guo, Linlang Cancer Manag Res Original Research OBJECTIVE: microRNAs are regulatory molecules regarded as important in the pathogenesis of different types of tumors. microRNA-216a (miR-216a-5p) has been identified as a tumor suppressor in multiple malignancies. However, the role of miR-216a-5p in the pathogenesis of small cell lung cancer (SCLC) remains obscure. The objective of this study was to investigate the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. MATERIALS AND METHODS: All the experimental methods used were as follows: microarray analysis, cell culture, transient, and stable gene transfection; real-time fluorescence PCR; Western blot; flow cytometry for cell cycle analysis; in vitro proliferation assay; in vitro wound healing experiment; in vivo xenograft model in nude mice; and dual luciferase reporter assay. All statistical analyses were carried out using GraphPad Prism 7 software. Statistical significance was analyzed by Student’s t-test or one-way ANOVA. P <0.05 (typically compared with the negative control group) was considered as significant and is marked with an asterisk in the figures. RESULTS: In this study, we observed that miR-216a-5p is downregulated in SCLC cell lines compared to that in the normal human bronchial epithelial cell line 16-HBE. In vitro and in vivo experiments demonstrate that upregulation of miR-216a-5p significantly decreased cell growth and migration and its downregulation increased SCLC cell proliferation and migration and influenced the cell cycle. Using bioinformatics analyses, we predicted that the important antiapoptotic gene Bcl-2 is targeted by miR-216a-5p, and we identified a functional miR-216a-5p binding site in the 3′-UTR of Bcl-2 using luciferase reporter assay. Furthermore, we determined that suppression of miR-216a-5p modulated the expression of Bcl-2, Bax, and Bad proteins (Bcl-2 family proteins), while Bcl-2 knockdown abrogated the effect of miR-216a-5p downregulation on cell proliferation, cell migration, and the cell cycle. CONCLUSION: Taken together, these findings suggest that miR-216a-5p regulates SCLC biology via Bcl-2 family proteins. Therefore, our study highlights the role of the miR-216a-5p/Bcl-2 axis in SCLC pathogenesis. Dove Medical Press 2018-10-18 /pmc/articles/PMC6201844/ /pubmed/30425570 http://dx.doi.org/10.2147/CMAR.S178380 Text en © 2018 Sun et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sun, Yanqin
Hu, Bingshuang
Wang, Yanhong
Li, Zhen
Wu, Jingfang
Yang, Yunchu
Wei, Yue
Peng, Xiaofeng
Chen, Hongling
Chen, Rongqi
Jiang, Pingyan
Fang, Sixian
Yu, Zhiwu
Guo, Linlang
miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
title miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
title_full miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
title_fullStr miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
title_full_unstemmed miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
title_short miR-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the Bcl-2 family proteins
title_sort mir-216a-5p inhibits malignant progression in small cell lung cancer: involvement of the bcl-2 family proteins
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201844/
https://www.ncbi.nlm.nih.gov/pubmed/30425570
http://dx.doi.org/10.2147/CMAR.S178380
work_keys_str_mv AT sunyanqin mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT hubingshuang mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT wangyanhong mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT lizhen mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT wujingfang mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT yangyunchu mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT weiyue mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT pengxiaofeng mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT chenhongling mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT chenrongqi mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT jiangpingyan mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT fangsixian mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT yuzhiwu mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins
AT guolinlang mir216a5pinhibitsmalignantprogressioninsmallcelllungcancerinvolvementofthebcl2familyproteins